1.
Adabag AS,
Luepker RV,
Roger VL,
Gersh BJ.
Sudden cardiac death: epidemiology and risk factors.
Nat Rev Cardiol 2010;4:216-25.
2.
Myerburg RJ,
Kessler KM and Castellanos A.
Sudden cardiac death.
Structure,
function,
and time-dependence of risk.
Circulation 1992;85:Suppl-10 (mancano le pagine!).
3.
Zipes DP,
Camm AJ,
Borggrefe M et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Circulation 2006;114:e385-e484.
4.
Wu TJ,
Ong JJ,
Hwang C,
et al.
Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry.
J Am Coll Cardiol 1998;32:187-96.
5.
Gulati A,
Jabbour A,
Ismail TF et al.
Association of fibrosis with mortality and sudden cardiac death in patients with non-ischemic dilated cardiomyopathy.
JAMA 2013;309:896-908.
6.
Chan RH,
Maron BJ,
Olivotto I et al.
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Circulation 2014;130:484-95.
7.
Connolly SJ,
Hallstrom AP,
Cappato R,
et al.
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.
AVID,
CASH and CIDS studies.
Antiarrhythmics vs Implantable Defibrillator study.
Cardiac Arrest Study Hamburg.
Canadian Implantable Defibrillator Study.
Eur Heart J 2000;21:2071-8.
8.
Theuns DA,
Smith T,
Hunink MG,
Bardy GH,
Jordaens L.
Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.
Europace 2010;12:1564-70.
9.
Epstein AE,
DiMarco JP,
Ellenbogen KA et al.
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
J Am Coll Cardiol 2013;61:e6-75.
10.
Wang TJ,
Evans JC,
Benjamin EJ,
et al.
Levy D,
LeRoy EC,
Vasan RS.
Natural history of asymptomatic left ventricular systolic dysfunction in the community.
Circulation.
2003;108:977–982.